Mergers & Acquisitions

Xiidra is a prescription eye drop used to treat dry eye disease.

The Blink portfolio consists of various eye and contact lens rewetting drops.

The business could be worth as much as $800 million.

The grocer is expected to open a second location in the Hampton Roads area in early 2025.

Rite Aid’s retail pharmacy segment revenues increased 3.4% over the prior year quarter driven by an increase in acute and maintenance prescriptions.

RK Pharma said the acquisition will give the company an exciting product portfolio, meaningful partnerships and a proven team with an impressive track record.

Upon completion of Kroger’s merger with Albertsons, the combined company expects to donate 10 billion meals by 2030 to feed people struggling with hunger.

AbbVie accused Coherus of breaching a previous agreement, granting a license for a biosimilar of Humira, leading Coherus to file a restraining order to prevent termination of the licensing deal.